Skip to main content
    U

    U.S. Physical Therapy, Inc. (USPH)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $99.58
    -0.02 (-0.02%)

    Market Cap: $1.49B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    U.S. Physical Therapy, Inc. (USPH) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    U.S. Physical Therapy (USPH) trades at 37.2x trailing earnings and 1.8x sales. Its P/E of 37.2x is above its 5-year median of 33.1x. Its forward P/E is 32.9x. The median P/E across 8 similar companies is 22.8x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 13.1% higher over the next year. Its free cash flow yield is 4.6%.

    MultipleValue
    P/E (trailing)37.2x
    Forward P/E32.9x
    Price to sales1.8x
    Price to book3.5x
    EV/EBITDA17.0x
    Price to FCF21.5x
    EV/FCF24.5x
    PEG3.3
    FCF yield4.6%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 2.5% above 36.3x, its P/S is 21.7% below 2.3x and its P/B is 16.7% below 4.2x.

    MultipleCurrent5-year median10-year median
    P/E37.2x33.1x36.3x
    P/S1.8x2.0x2.3x
    P/B3.5x2.9x4.2x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 29.8x in 2025 to 50.3x in 2020. 2025 was the lowest of those years.

    Year endPriceP/EP/SP/B
    2025$78.0929.8x1.5x2.5x
    2024$88.7136.4x2.0x2.7x
    2023$93.1436.4x2.2x2.9x
    2022$81.0329.9x1.9x3.3x
    2021$95.5530.1x2.5x4.2x
    2020$120.2550.3x3.6x5.6x
    2019$114.3540.5x3.0x6.1x
    2018$102.3548.7x2.9x6.0x
    2017$72.2035.4x2.1x4.4x
    2016$70.2036.6x2.4x4.7x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About USPH

    What is USPH's forward P/E ratio?

    U.S. Physical Therapy has a forward P/E ratio of 32.9x.

    Is USPH stock overvalued?

    GNG's valuation label for USPH is Undervalued. Its P/E of 37.2x compares with a median of 22.8x across 8 similar companies.

    What is USPH's price to sales ratio?

    U.S. Physical Therapy has a price to sales ratio of 1.8x.

    What is U.S. Physical Therapy's average P/E ratio over 5 years?

    U.S. Physical Therapy's median P/E over the last 5 years is 33.1x, from 60 month-end values through Oct 2026.

    What is USPH's PEG ratio?

    U.S. Physical Therapy has a PEG ratio of 3.3.